Point72 Hong Kong LTD Zymeworks Inc. Transaction History

Point72 Hong Kong LTD

  • $1.54 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$24.28 - $49.8 $11,314 - $23,206
-466 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$24.84 - $45.46 $11,575 - $21,184
466 New
466 $21,000
Q3 2019

Nov 14, 2019
SELL
$22.78 - $29.08 $10,615 - $13,551
-466 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$11.13 - $21.86 $5,186 - $10,186
466 New
466 $7,000

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $762M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email